Literature DB >> 10490647

Developmental effects of ectopic expression of the glucocorticoid receptor DNA binding domain are alleviated by an amino acid substitution that interferes with homeodomain binding.

J M Wang1, G G Préfontaine, M E Lemieux, L Pope, M A Akimenko, R J Haché.   

Abstract

Steroid hormone receptors are distinguished from other members of the nuclear hormone receptor family through their association with heat shock proteins and immunophilins in the absence of ligands. Heat shock protein association represses steroid receptor DNA binding and protein-protein interactions with other transcription factors and facilitates hormone binding. In this study, we investigated the hormone-dependent interaction between the DNA binding domain (DBD) of the glucocorticoid receptor (GR) and the POU domains of octamer transcription factors 1 and 2 (Oct-1 and Oct-2, respectively). Our results indicate that the GR DBD binds directly, not only to the homeodomains of Oct-1 and Oct-2 but also to the homeodomains of several other homeodomain proteins. As these results suggest that the determinants for binding to the GR DBD are conserved within the homeodomain, we examined whether the ectopic expression of GR DBD peptides affected early embryonic development. The expression of GR DBD peptides in one-cell-stage zebra fish embryos severely affected their development, beginning with a delay in the epibolic movement during the blastula stage and followed by defects in convergence-extension movements during gastrulation, as revealed by the abnormal patterns of expression of several dorsal gene markers. In contrast, embryos injected with mRNA encoding a GR peptide with a point mutation that disrupted homeodomain binding or with mRNA encoding the DBD of the closely related mineralocorticoid receptor, which does not bind octamer factors, developed normally. Moreover, coinjection of mRNA encoding the homeodomain of Oct-2 completely rescued embryos from the effects of the GR DBD. These results highlight the potential of DNA-independent effects of GR in a whole-animal model and suggest that at least some of these effects may result from direct interactions with homeodomain proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490647      PMCID: PMC84705          DOI: 10.1128/MCB.19.10.7106

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  104 in total

Review 1.  POU-domain transcription factors: pou-er-ful developmental regulators.

Authors:  M G Rosenfeld
Journal:  Genes Dev       Date:  1991-06       Impact factor: 11.361

2.  Molecular nature of Spemann's organizer: the role of the Xenopus homeobox gene goosecoid.

Authors:  K W Cho; B Blumberg; H Steinbeisser; E M De Robertis
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

3.  A cell autonomous function of Brachyury in T/T embryonic stem cell chimaeras.

Authors:  P Rashbass; L A Cooke; B G Herrmann; R S Beddington
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

4.  Interactions of the Oct-1 POU subdomains with specific DNA sequences and with the HSV alpha-trans-activator protein.

Authors:  T M Kristie; P A Sharp
Journal:  Genes Dev       Date:  1990-12       Impact factor: 11.361

Review 5.  Regulation of transcription and cell identity by POU domain proteins.

Authors:  G Ruvkun; M Finney
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

6.  Organizer-specific homeobox genes in Xenopus laevis embryos.

Authors:  B Blumberg; C V Wright; E M De Robertis; K W Cho
Journal:  Science       Date:  1991-07-12       Impact factor: 47.728

7.  New type of POU domain in germ line-specific protein Oct-4.

Authors:  H R Schöler; S Ruppert; N Suzuki; K Chowdhury; P Gruss
Journal:  Nature       Date:  1990-03-29       Impact factor: 49.962

8.  Ubiquitous transcription factor OTF-1 mediates induction of the MMTV promoter through synergistic interaction with hormone receptors.

Authors:  U Brüggemeier; M Kalff; S Franke; C Scheidereit; M Beato
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

9.  Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities.

Authors:  X K Zhang; K N Wills; M Husmann; T Hermann; M Pfahl
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

10.  Oct-4: a germline-specific transcription factor mapping to the mouse t-complex.

Authors:  H R Schöler; G R Dressler; R Balling; H Rohdewohld; P Gruss
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

View more
  5 in total

1.  Cross-talk between glucocorticoid and retinoic acid signals involving glucocorticoid receptor interaction with the homoeodomain protein Pbx1.

Authors:  Nanthakumar Subramaniam; Javier Campión; Ingalill Rafter; Sam Okret
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

2.  Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces.

Authors:  J G Savory; G G Préfontaine; C Lamprecht; M Liao; R F Walther; Y A Lefebvre; R J Haché
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

3.  Characterization of conserved tandem donor sites and intronic motifs required for alternative splicing in corticosteroid receptor genes.

Authors:  Caroline Rivers; Andrea Flynn; Xiaoxiao Qian; Laura Matthews; Stafford Lightman; David Ray; Michael Norman
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

4.  Alterations to Placental Glucocorticoid Receptor Expression with Alcohol Consumption.

Authors:  S L Young; Z Saif; A S Meakin; E S McMaster; N Hayes; L A Gallo; N Reid; K M Moritz; V L Clifton
Journal:  Reprod Sci       Date:  2021-01-06       Impact factor: 3.060

5.  The uniform-score gene set analysis for identifying common pathways associated with different diabetes traits.

Authors:  Hao Mei; Lianna Li; Shijian Liu; Fan Jiang; Michael Griswold; Thomas Mosley
Journal:  BMC Genomics       Date:  2015-04-23       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.